| Blueprint Medicines (Switzerland) GmbH - Ayvakyt 50 mg, Filmtabletten | | 68294 | | 02 | | Ayvakyt 50 mg | | Filmtabletten | | L01EX18 | | Avapritinib | | 06.07.2023 | | |
| | Composition | | avapritinibum 50 mg, cellulosum microcristallinum, copovidonum, carmellosum natricum conexum corresp. natrium max. 0.543 mg, magnesii stearas, Überzug: talcum, macrogolum 3350, poly(alcohol vinylicus), E 171, pro compresso obducto. | | Packungsbestandteile | | Filmtabletten | | | | Active Agent | Dose |
|---|
| Avapritinibum | 50 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | Copovidonum | | | | E 171 | | color. | | Macrogolum | 3350 | | | Magnesii Stearas | | | | Poly(Alcohol Vinylicus) | | | | Pro Compresso Obducto | | | | Talcum | | Überzug |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | 30 | PR | PR | A | | No |
|
|
